VAPB and amyotrophic lateral sclerosis: More research on these cells could open the way to investigate the effects of drugs that target specific cellular pathways, with the prospect of developing novel therapeutic approaches; these could be relevant not only for ALS8 but also for more common typical ALS or for a subset of ALS cases that share a VAP deficit with ALS8.